F.D.A. Faces Upset Over Denials of New Drugs
Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But patients with rare diseases view recent decisions as signs that the doors are closing on their options. [Source]
Publication Date:Origin: nytimes.com
Category: Regulation and Deregulation of Industry
Topics: options, closing, doors, signs, decisions, recent, diseases, patients, industry, stamp”, “rubber, vowing, while, treatments, reviews, promise, officials, Agency, Drugs, Denials, Upset, Faces
Source: https://www.nytimes.com/2026/03/05/health/fda-drugs-rare-diseases-rfk-jr.html